Stocks
Oculis Holding AGOCSAW
NASDAQHealthcareBiotechnology$2.39
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing ophthalmic therapies, with a lead candidate for dry eye disease and a pipeline targeting other eye conditions. It operates as a holding company with subsidiaries in Switzerland and the U.S., and its stock trades with warrants under the OCSAW ticker.
52W Range: $2.37-$2.39
Congressional Interest in Oculis Holding AG (OCSAW)
No congressional trades have been disclosed for Oculis Holding AG (OCSAW) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading OCSAW?
No congressional trades found for this stock.